Indications and Purposes
| 1 Indications And Usage Thalomid In Combination With Dexamethasone Is Indicated For The Treatment Of Patients With Newly Diagnosed Multiple Myeloma (Mm). ( 1.1 ) Thalomid Is Indicated For The Acute Treatment Of The Cutaneous Manifestations Of Moderate To Severe Erythema Nodosum Leprosum (Enl). Thalomid Is Not Indicated As Monotherapy For Such Enl Treatment In The Presence Of Moderate To Severe Neuritis. Thalomid Is Also Indicated As Maintenance Therapy For Prevention And Suppression Of The Cutaneous Manifestations Of Enl Recurrence. ( 1.2 ) 1.1 Multiple Myeloma Thalomid In Combination With Dexamethasone Is Indicated For The Treatment Of Patients With Newly Diagnosed Multiple Myeloma (Mm) [See Clinical Studies (14.1) ] . 1.2 Erythema Nodosum Leprosum Thalomid Is Indicated For The Acute Treatment Of The Cutaneous Manifestations Of Moderate To Severe Erythema Nodosum Leprosum (Enl). Thalomid Is Not Indicated As Monotherapy For Such Enl Treatment In The Presence Of Moderate To Severe Neuritis. Thalomid Is Also Indicated As Maintenance Therapy For Prevention And Suppression Of The Cutaneous Manifestations Of Enl Recurrence [See Clinical Studies (14.2) ]. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Thalidomide |
|
ZINC1530947 |